Theravance Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-25

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Theravance is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule medicines for the treatment of diseases including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates. Of its five programs in development, two are in late stage, its telavancin program focusing on treating serious Gram-positive bacterial infections with Astellas and its Beyond Advair collaboration with GSK.

    The company's total revenues increased at a CAGR of 235% during 2002-2006, from $0.1 million to $20 million. This represents an absolute total growth of $19 million during the historical period. License, collaboration and other revenues including milestone and upfront payments contributed all of the company's revenues.

    Theravance's total revenues are estimated to increase at a CAGR of 71% between 2006 and 2010, from $20 million to $168 million. Royalties on telavancin sales will be the major contributor to the company's total growth out to 2010.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: theravance inc cost cap market telavancin analysis financial humphreys patrick

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.